Glanbia initiated with a Buy at Mizuho

Mizuho initiated coverage of Glanbia with a Buy rating and EUR 26 price target. The analyst believes the company “provides differentiated exposure to the structural growth of active nutrition.” As the market share leader, Glanbia differs from public-traded peers for in-house manufacturing, diversification across regions, brands, formats, and industry-leading marketing, the analyst tells investors in a research note.